Breast Cancer Liquid Biopsy Market to hit USD 1.9 billion by 2032, says Global Market Insights Inc.
06 janv. 2025 04h00 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Breast cancer liquid biopsy market size reached USD 305.9 million in 2023 and is projected to expand at a robust CAGR of 22.6% from 2024 to...
Burning Rock Announces Results of 2024 Annual General Meeting
31 déc. 2024 04h56 HE
|
Burning Rock Biotech Limited
Burning Rock Announces Results of 2024 Annual General Meeting
Burning Rock Reports Third Quarter 2024 Financial Results
03 déc. 2024 23h59 HE
|
Burning Rock Biotech Limited
Burning Rock Reports Third Quarter 2024 Financial Results
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
03 déc. 2024 06h45 HE
|
Burning Rock Biotech Limited
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
05 nov. 2024 09h00 HE
|
PrognomiQ
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
10 oct. 2024 23h16 HE
|
Burning Rock Biotech Limited
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
Burning Rock Announces Changes to Management and Board of Directors
27 sept. 2024 08h37 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Reports Second Quarter 2024 Financial Results
22 août 2024 23h59 HE
|
Burning Rock Biotech Limited
Burning Rock Reports Second Quarter 2024 Financial Results
Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
19 août 2024 02h21 HE
|
Burning Rock Biotech Limited
Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
Diadem Appoints Michael Rasche as Chief Executive Officer
10 juil. 2024 07h00 HE
|
Diadem SpA
Industry veteran Michael Rasche named CEO of Diadem, a leader in developing blood tests for the early prediction of progression to Alzheimer’s disease.